Volibo M 0.3 Tablet
Volibo M 0.3 Tablet is an anti-diabetic medicine used to manage type 2 diabetes mellitus in adults. It helps control high blood sugar levels, which is essential for preventing long-term complications of diabetes.
Uses:
- Treatment of type 2 diabetes mellitus
Benefits:
- Controls post-meal and overall blood glucose levels
- Helps remove excess glucose from the body through urine
- Reduces risk of diabetes-related complications, including kidney damage, eye damage, nerve problems, and limb loss
- Lowers risk of cardiovascular disease in patients with type 2 diabetes and existing heart conditions
- Works best when combined with healthy diet, regular exercise, and weight management
How it works:
Volibo M 0.3 Tablet is a combination of two antidiabetic medicines that act together to regulate blood sugar:
- Slows down the breakdown of carbohydrates in the intestines, reducing post-meal glucose spikes
- Increases elimination of excess glucose through urine
How to use:
- Take as advised by your doctor
- Swallow whole; do not chew, crush, or break
- Take with or immediately after food
- If a dose is missed, take it as soon as possible. If it’s almost time for the next dose, skip the missed dose. Do not double doses
Side effects:
Most side effects are mild and temporary. Consult your doctor if they persist or worry you.
Common side effects include:
- Abdominal pain
- Vomiting
- Decreased appetite
- Flatulence
- Diarrhea
Safety Advice:
- Alcohol: Unsafe, avoid consumption
- Pregnancy & Breastfeeding: Safety not established; consult your doctor
- Driving: Usually safe, but patients should be aware of hypoglycemia risk, especially if combined with other antidiabetic agents like sulfonylureas or insulin
- Kidney: Use with caution; regular monitoring recommended; not for severe kidney disease
- Liver: Limited data; consult your doctor before use
Volibo M 0.3 Tablet is designed to help manage blood sugar effectively and reduce the risk of diabetes-related complications when used consistently as part of a comprehensive treatment plan.



Reviews
There are no reviews yet.